Curis Inc CRIS

NAS: CRIS | ISIN: US2312692005 16/10/2026

0,407 USD (-19,86%)

(-19,86%) 16/10/2026

Grafiek Curis Inc

Grafiek Curis Inc

1 dag1d -19,86%
1 week1w -36,72%
1 maand1m -62,65%
3 maanden3m -91,21%
6 maanden6m -32,49%
1 jaar1j -73,56%
5 jaar5j -94,52%

Curis Inc in het nieuws

Toon enkel gratis nieuws

16 oktober 2026 · Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors · Persbericht

13 augustus 2026 · Curis, Inc. Announces Pricing of $5.6 Million Public Offering · Persbericht

30 juli 2026 · Curis Doses First Five Patients in TakeAim CLL Study · Persbericht

22 juli 2026 · Curis Announces Positive Emavusertib Update · Persbericht

6 juli 2026 · Curis Consents First Six Patients in TakeAim CLL Study · Persbericht

26 juni 2026 · Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split · Persbericht

12 mei 2026 · Curis Provides First Quarter 2026 Business Update · Persbericht

5 mei 2026 · Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026 · Persbericht

19 maart 2026 · Curis Provides Fourth Quarter 2025 Business Update · Persbericht

12 maart 2026 · Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 · Persbericht

Profiel Curis Inc

Gezondheidstechnologie

Productie van biologische producten

Website: www.curis.com

Hoofdzetel: Lexington, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe